Background-In controlled human exposure studies, diesel engine exhaust inhalation impairs vascular function and enhances thrombus formation. The aim of the present study was to establish whether an exhaust particle trap could prevent these adverse cardiovascular effects in men. Methods and Results-Nineteen healthy volunteers (mean age, 25Ϯ3 years) were exposed to filtered air and diesel exhaust in the presence or absence of a particle trap for 1 hour in a randomized, double-blind, 3-way crossover trial. Bilateral forearm blood flow and plasma fibrinolytic factors were assessed with venous occlusion plethysmography and blood sampling during intra-arterial infusion of acetylcholine, bradykinin, sodium nitroprusside, and verapamil. Ex vivo thrombus formation was determined with the use of the Badimon chamber. Compared with filtered air, diesel exhaust inhalation was associated with reduced vasodilatation and increased ex vivo thrombus formation under both low-and high-shear conditions. The particle trap markedly reduced diesel exhaust particulate number (from 150 000 to 300 000/cm 3 to 30 to 300/cm 3 ; PϽ0.001) and mass (320Ϯ10 to 7.2Ϯ2.0 g/m 3 ; PϽ0.001), and was associated with increased vasodilatation, reduced thrombus formation, and an increase in tissue-type plasminogen activator release. Conclusions-Exhaust particle traps are a highly efficient method of reducing particle emissions from diesel engines. With a range of surrogate measures, the use of a particle trap prevents several adverse cardiovascular effects of exhaust inhalation in men. Given these beneficial effects on biomarkers of cardiovascular health, the widespread use of particle traps on diesel-powered vehicles may have substantial public health benefits and reduce the burden of cardiovascular disease. Clinical Trial Registration-http://www.clinicaltrials.gov.
infarction. 10 Despite the strength and consistency of observational studies, the underlying pathophysiological mechanisms remain unclear. Using well characterized and controlled diesel engine exhaust exposure studies in healthy volunteers, we have previously demonstrated impaired vascular vasomotor and fibrinolytic function, 11 increased arterial stiffness, 12 and enhanced ex vivo thrombus formation. 13 Furthermore, in patients with coronary heart disease, we have shown that diesel engine exhaust inhalation exacerbates exercise-induced ST-segment depression during light exercise. 14 Taken together, these adverse cardiovascular effects provide important mechanisms that help to explain the detrimental health effects of air pollution exposure.
One approach to limit traffic emissions has been the introduction of diesel engine exhaust particle traps or filters. Although the efficiency of particle traps to reduce particle emission is Ͼ90%, particles are not completely eliminated, and traps have the potential to create new and potentially more toxic particles that may outweigh the benefits of reducing the emitted particle mass. 15 We therefore sought to determine whether the introduction of a particle trap would attenuate or worsen the adverse cardiovascular effects of diesel engine exhaust inhalation. [11] [12] [13] [14] Methods Twenty-one subjects were screened, and 1 subject was excluded at the initial screening. A further subject was excluded after randomization because of inability to complete all exposures, leaving 19 healthy nonsmoking men who completed the full study protocol (see Figure I in the online-only Data Supplement). The study was approved by the local research ethics committee and conducted in accordance with the Declaration of Helsinki and with the written informed consent of all volunteers.
All subjects had normal lung function and no symptoms of upper airway infection for the 4 weeks before or during the study. Exclusion criteria were regular medication, clinical evidence of atherosclerotic vascular disease, arrhythmias, diabetes mellitus, hypertension, renal or hepatic failure, asthma, significant occupational exposure to air pollution, or intercurrent illness. All subjects abstained from caffeine-containing drinks or food for at least 4 hours and from alcohol for 24 hours before each assessment.
Study Design
The primary end points were endothelial vasomotor and fibrinolytic function and ex vivo thrombus formation. Secondary end points were soluble markers of inflammation and platelet activation. Exploratory end points were markers of arterial stiffness and airway inflammation. Sample size was determined a priori and based on power calculations for the primary end points derived from our previous studies (see the online-only Data Supplement). 11, 13 In a randomized, double-blind, 3-way crossover design, subjects were exposed to filtered air, unfiltered dilute diesel engine exhaust, and dilute diesel engine exhaust that had passed through a particle trap. The order of the exposures was randomized, with an independent predetermined exposure sequence. Exposures were performed at a separate dedicated exposure facility by technical staff with no involvement in the clinical studies. Clinical studies were performed in a dedicated clinical research facility by clinical staff blinded to exposure allocation. Exposures were separated by at least 1 week and performed in a purpose-built exposure chamber, according to a previously described standard protocol. 11 During each 1-hour exposure, subjects performed moderate exercise (minute ventilation, 25 L/min per m 2 body) on a bicycle ergometer for 15 minutes alternated with 15 minutes of rest.
Diesel Exhaust
A Volvo diesel engine (Volvo TD40 GJE, 4.0 L, 4 cylinders) running on Volvo standard diesel fuel (SD-VSD-10) was used to generate the diesel exhaust. The specification of the Volvo diesel fuel is similar to the European automotive standard diesel (EN590), with a sulfur content of 5 to 7 mg/kg and polycyclic aromatic hydrocarbon content of 2% to 6% by mass. The engine worked under transient speed and load conditions in accordance with the standardized European transient cycle that mimics real-world urban driving conditions. 16 More than 90% of the exhaust was shunted away, and the residual exhaust was mixed with filtered air (Figure 1) .
The concentrations of nitrogen oxides (NO, NO 2 , and other nitrogen oxides) in the chamber were monitored continuously together with total gaseous hydrocarbons. During diesel exhaust exposures, we sought to generate a PM mass concentration of 300 g/m
3
. This PM mass concentration was maintained for the inlet conditions of the particle trap. Actual exposure was measured gravimetrically with standard glass fiber filter sampling together with the use of a tapered element oscillating microbalance online instrument and in accordance with a wellestablished protocol, as described previously. 17 In addition, a scanning mobility particle sizer system was used to determine fine (Ͻ1 m) particle number concentration.
Particle Trap
The particle trap (diesel particulate filter-continuously regenerating trap [DPF-CRT], Johnson Matthey, Royston, UK) used is an unmodified, continuously regenerating trap filter, available commercially throughout the world as a factory-fit option or as a retrofit unit to buses and heavy goods vehicles. It is similar in design to filters produced by a number of manufacturers. It consists of a honeycomb-like complex of channels through which the exhaust is passed. A catalyst at the front of the filter oxidizes part of the NO gas in the exhaust into NO 2 , which flows through the particle filter and subsequently reacts with trapped carbonaceous particles to generate CO 2 and N 2 . This increases NO 2 levels in the exhaust after the particle trap, without causing significant changes in total nitrogen oxide concentrations, while achieving an efficient reduction in particle emissions.
Vascular Studies
On the basis of data from previous exposure studies, 13, 14, 16, 18 vascular assessment was performed 6 to 8 hours after each exposure. Assessments were performed with subjects resting supine in a quiet temperature-controlled (22°C to 24°C) room. Venous cannulas (17 gauge) were inserted into large subcutaneous veins in the antecubital fossae of both arms. The brachial artery of the nondominant arm was cannulated with a 27-standard-wire-gauge steel needle. After a baseline 30-minute saline infusion, bradykinin at 100, 300, and 1000 pmol/min (endothelium-dependent vasodilator that releases tissuetype plasminogen activator [tPA]; Merck Biosciences, Nottingham, UK); acetylcholine at 5, 10, and 20 g/min (endothelium-dependent vasodilator that does not release tPA; Merck Biosciences); and sodium nitroprusside at 2, 4, and 8 g/min (endotheliumindependent vasodilator that does not release tPA; David Bull Laboratories, Warwick, UK) were infused for 6 minutes at each dose. The 3 vasodilators were given in random order, separated by a 20-minute saline infusion. Verapamil was infused at 10, 30, and 100 g/min (endothelium-independent and NO-independent vasodilator that does not release tPA) at the end of the study protocol. The infusion of these vasodilators was undertaken to allow the assessment of distinct aspects of vascular function, including NO, endothelium, fibrinolysis, and vasomotion.
Forearm blood flow was measured in both infused and noninfused arms with venous occlusion plethysmography incorporating mercury-in-silicone elastomer strain gauges as described previously. 11 Heart rate and blood pressure were monitored in the noninfused arm throughout each study with a noninvasive, semiautomated oscillometric sphygmomanometer (Boso Medicus, Jungingen, Germany). Blood was drawn simultaneously from the venous cannulas in each arm at baseline and during infusion of each dose of bradykinin. Samples were collected into acidified buffered citrate (Stabilyte, Biopool International) for tPA assays and into citrate (BD Vacutainer) for plasminogen activator inhibitor type 1 assays. Samples were kept on ice before being centrifuged at 2000g for 30 minutes at 4°C. Platelet-free plasma was decanted and stored at Ϫ80°C before assay. Plasma tPA and plasminogen activator inhibitor type 1 antigen concentrations were determined by enzyme-linked immunosorbent assay (TintElize tPA, Biopool EIA, Trinity Biotech, Ireland; Coaliza plasminogen activator inhibitor type 1, Chromogenix AB, Milan, Italy). Hematocrit was determined by capillary tube centrifugation of samples collected at baseline and during infusion of bradykinin at 1000 pmol/min.
Inflammatory Measures
Venous blood samples were obtained before and at 2, 6, and 8 hours after exposure. Samples were analyzed for total and differential cell count with an autoanalyzer. Plasma interleukin-6, tumor necrosis factor-␣, soluble CD40 ligand, soluble P-selectin, intercellular adhesion molecule-1, and C-reactive protein were measured with commercially available enzyme-linked immunosorbent assays (R&D Systems, Abingdon, UK).
Ex Vivo Thrombosis Studies
On the basis of previous studies, 13 ex vivo thrombus formation was determined with the use of the Badimon chamber 2 hours after each exposure. In brief, a pump was used to draw blood from an antecubital vein through a series of 3 cylindrical perfusion chambers maintained at 37°C in a water bath. Carefully prepared strips of porcine aorta, from which the intima and a thin layer of media had been removed, acted as the thrombogenic substrate. The rheological conditions in the first chamber simulate those of patent coronary arteries (low-shear rate, Ϸ212 s Ϫ1 ), and those in the second and third chambers simulate those of mildly stenosed coronary arteries (highshear rate, Ϸ1690 s Ϫ1 ). The model thus acts as one of deep coronary arterial injury. Each study lasted for 5 minutes, during which flow was maintained at a constant rate of 10 mL/min. All studies were performed with the same perfusion chamber, by the same operator, and according to a well-established protocol. 13 Immediately after each study, porcine strips with thrombus attached were removed and fixed in 4% paraformaldehyde. Strips were paraffin-wax embedded, sectioned, and stained with Masson's trichrome. Images were acquired at ϫ20 magnification, and thrombus area was measured with a semiautomated image acquisition system (Ariol, Applied Imaging) by a blinded operator. Results from at least 6 sections were averaged to determine thrombus area for each chamber as described previously. 19, 20 
Assessment of Arterial Stiffness
Please see the online-only Data Supplement.
Assessment of Airway Inflammation
Data Analysis and Statistics
Plethysmographic data were analyzed as described previously. 11 Estimated net release of tPA antigen was defined as the product of the infused forearm plasma flow (based on the mean hematocrit and the infused forearm blood flow) and the concentration difference between the infused and noninfused arms, as described previously. 11, 14 Continuous variables are reported as meanϮSEM. Statistical analyses were performed with GraphPad Prism (Graph Pad Software, CA). All studies, data analysis, and data exclusion were performed before the data were unblinded.
To address our primary hypothesis, the analysis plan required 2 independent assessments of the responses in the 3 randomized arms of the study. First, to confirm our previous findings, we assessed whether the inhalation of diesel engine exhaust impaired vascular function and promoted thrombogenesis. Second, we assessed whether the particle trap improved these surrogate measures of cardiovascular health. Comparisons between exposures were undertaken with a 2-sided paired t test and 2-way ANOVA with repeated measures, as appropriate. Factors assessed in the 2-way ANOVA were exposure and vasodilator dose. Exposure data were analyzed with a 2-sided unpaired t test. Statistical significance was taken at PϽ0.05.
Results
The 19 healthy male volunteers were young and normotensive, and had normal lung function (Table 1 ). All volunteers completed the 3 study visits. Exposures were well tolerated, with no adverse symptoms reported.
The particle trap reduced the total particle mass concentration in the chamber by Ϸ98% and the fine (Ͻ1 m) particle number concentration by Ͼ99.8%. As anticipated, the particle trap, with an integrated oxidation catalyst, altered the composition of nitrogen oxides (ie, increased NO 2 and decreased NO) ( Table 2 ). However, it had no significant effect on the concentrations of gaseous hydrocarbons.
There were no changes in blood pressure, resting heart rate, baseline forearm blood flow, or markers of arterial stiffness in between the 3 study visits (Tables II and III in 
Vascular Studies

Vasomotor Function
There was a dose-dependent increase in forearm blood flow with both endothelium-dependent (bradykinin and acetylcholine) and endothelium-independent (sodium nitroprusside and verapamil) vasodilators after each exposure (PϽ0.0001 for all; Figure 2) .
Compared with filtered air, vasodilatation was impaired after diesel engine exhaust exposure in response to bradykinin (Pϭ0.009), acetylcholine (Pϭ0.01), and verapamil (Pϭ0.03; Figure 2 ). There was no significant difference in response to sodium nitroprusside (Pϭ0.15; Figure 2 ). However, with the introduction of the particle trap, vasodilatation increased in response to all vasodilators: bradykinin (PϽ0.0001), acetylcholine (PϽ0.0001), verapamil (Pϭ0.001), and sodium nitroprusside (Pϭ0.04; Figure 2 ). Indeed, there were no differences in vasomotor responses between filtered air and filtered diesel engine exhaust except for acetylcholine, with which vasodilatation was lower with filtered air (Pϭ0.02).
Fibrinolytic Function
There were no differences in baseline plasma tPA and plasminogen activator inhibitor type 1 concentrations between exposures (Table VI in the online-only Data Supplement). There was a dose-dependent increase in tPA release in response to bradykinin infusion after each exposure (PϽ0.0001 for all; Figure 3) . Although numerically lower, there was no statistical difference in tPA release after exposure to diesel engine exhaust inhalation compared with filtered air (Pϭ0.30; Figure 3 ). However, application of the particle trap was associated with an improvement in the net release of tPA compared with unfiltered diesel engine exhaust (Pϭ0.03; Figure 3 ). There was no difference in tPA release between filtered air and filtered diesel engine exhaust (Pϭ0.22).
Ex Vivo Thrombosis
Compared with filtered air, inhalation of diesel exhaust was associated with an increase of thrombus formation in the low-shear (21.8%; PϽ0.001; Figure 4 ) and high-shear (14.8%; Pϭ0.02; Figure 4 ) chambers. Compared with unfiltered exhaust, the introduction of the particle trap was associated with a reduction in thrombus formation in the low-shear chamber (Ϫ15.7%; Pϭ0.02; Figure 4 ), whereas the apparent reduction in the high-shear chamber did not reach statistical significance (Pϭ0.11; Figure 4 ). There were no differences in thrombus formation between filtered air and filtered diesel exhaust (Pϭ0.78 and Pϭ0.76 for the low-and high-shear chambers, respectively).
Discussion
Short-term exposure to traffic-derived air pollution is associated with acute cardiovascular events. 9, 10, 21 In the present study, using complementary and relevant measures of cardiovascular health, we have reconfirmed the adverse effects of exposure to diesel engine exhaust on endothelial function and ex vivo thrombosis. In addition, for the first time, we demonstrate that reducing the particulate component of diesel exhaust with the use of a commercially available particle trap can prevent these detrimental cardiovascular effects. Our study provides support for the application of particle traps to diesel-powered vehicles to reduce urban particulate concentrations and limit a range of adverse cardiovascular effects of exposure to traffic-derived air pollution.
In a series of controlled exposure studies in human subjects, we have previously shown an impairment of vasomotor responses to endothelium-dependent and endotheliumindependent vasodilators after diesel exhaust exposure. 18 These observations are consistent with other reports of brachial artery vasoconstriction shortly after exposure to dilute diesel exhaust 22 and concentrated ambient particles. 23 Such vascular impairment is not restricted to vasomotor function. We have also demonstrated increased thrombogenicity with reduced tPA release from the endothelium, 11 enhanced platelet activation, 13 and increased ex vivo thrombus formation. 13 In the present study, we used a range of these complementary measures of cardiovascular function in a comprehensive assessment of the potential for particle traps to improve human health. We were able to confirm our earlier findings that diesel exhaust inhalation causes detrimental vascular and prothrombotic effects. On this occasion, we did not observe a statistically significant reduction in tPA release from the endothelium after diesel exhaust exposure, and this may represent a type II error or reflect the subtle differences between study protocols. However, more importantly, we were able to demonstrate that the introduction of a particle trap not only improved vasomotion, endogenous fibrinolysis, and ex vivo thrombosis but appeared to normalize them.
Although there are many potentially harmful components in ambient air pollution, traffic-derived fine and ultrafine particles are most closely and consistently linked to acute cardiovascular events. This has been the rationale for the development of, and legislation for, targeted interventions to reduce the particulate matter content of vehicle emissions. 24 Although there is little doubt that particle traps are effective in reducing PM mass and number, concerns have been raised regarding the oxidation catalysts required to regenerate and maintain filter efficiency, because they may alter the toxicity of particulate and gaseous emissions. For example, soot particles generated from a low-emission diesel engine appear to have greater cytotoxic and proinflammatory effects. 15 The potential for particle traps to reduce the adverse cardiovascular effects of diesel exhaust emissions therefore needs to be assessed in humans. In the present study, we observed no adverse cardiovascular effects arising from the use of a particle trap. In fact, the only difference between filtered air and filtered diesel exhaust observed for any variable we assessed was an enhancement of vasodilatation in response to acetylcholine after exposure to filtered diesel exhaust. Although this difference was statistically significant, it was numerically small, and unlikely to be of major physiological significance. In light of these factors, we suspect that this may be a result of a type I error, although we cannot rule out an effect related to alterations in 1 or more unmeasured gaseous components.
We used a commercially available particle trap to reduce particle emissions from a heavy-duty diesel engine operating under the transient cycling conditions used as the standard for engine testing across the European Union. Particle filtration markedly reduced the mass and number of particle emissions. Taken together with our previous findings and data from observational studies, we believe that this reduction is responsible for rectifying the adverse cardiovascular effects of diesel engine exhaust inhalation. As expected, oxidation catalysts within the particle trap altered the composition of nitrogen oxides, with an increase in NO 2 and decrease in NO concentrations. However, we have recently assessed the effects of NO 2 on healthy volunteers, and did not identify any adverse effects on vascular or fibrinolytic function. 25 Although we did not observe an effect on the other gaseous components of the exposure, we acknowledge that the particle trap may have altered the composition of the exposures beyond those variables assessed during this study.
Consistent with previous studies, 11, 16, 18 vasodilatation was impaired after exposure to diesel engine exhaust in response to bradykinin and acetylcholine. However, there was also a reduction in vasodilatation to verapamil, implying an additional calcium flux-dependent impairment of vascular smooth muscle function. A reduction in vasodilatation in response to verapamil has been demonstrated previously after exposure to diesel exhaust generated under transient engine speed and load, 16 but not when generated under idling conditions. 11 We have speculated previously that, in exhaust generated under transient running conditions, the higher diesel-related soot content and its associated (adsorbed) organic material may cause these additional vascular smooth muscle effects, and we believe that this observation warrants further investigation. 16 Interestingly, impaired vasodilatation in response to verapamil was also normalized by the introduction of a particle trap. Although variations in responses between studies with different exposure protocols might provide insights into the pathophysiological mechanisms responsible for the adverse vasomotor effects of diesel exhaust exposure, these studies were designed and powered to detect differences within rather than between studies. Thus, although tempting, we believe that we should be cautious and circumspect in drawing conclusions from comparisons made between studies and that any such differences should be regarded as hypothesis generating and the subject of future investigations.
The exact mechanisms underlying the vascular and prothrombotic effects we observed in the current and previous studies remain only partially understood. Regarding the increase in ex vivo thrombosis seen after diesel exhaust exposure, data from previous in vitro 26 and animal studies, 27 as well as our own previous controlled exposure studies in humans, 13 suggest that platelet activation plays a central role. Platelets are key components of arterial thrombosis, a process that underpins acute coronary syndromes, including myocardial infarction. Platelet-leukocyte aggregates, increasingly recognized as the gold standard measure of in vivo platelet activation, 28 were increased after tracheal instillation of carbon nanotubes in a murine model of vascular injury 29 and after diesel exhaust exposure in humans. 13 Debate remains regarding whether inhaled components of diesel exhaust can translocate into the systemic circulation to mediate direct effects on blood and vascular components, 30, 31 or whether the induction of pulmonary inflammation and the subsequent generation of free radicals may activate platelets by reducing endothelium-and platelet-derived nitric oxide and antioxidants. Although a single observational study reported a small reduction in prothrombin time associated with ambient exposure to PM 10 , 32 the authors are not aware of any controlled exposure study demonstrating an effect of pollution exposure on plasma concentrations of coagulation factors.
The potential mechanisms underlying the adverse vasomotor effects observed in response to diesel exhaust exposure remain only partly understood, 33 and a full discussion is beyond the scope of this article. However, on the basis of data from our earlier studies in which the exposure was generated by an idling diesel engine, 11, 18 we have speculated previously that oxidative stress and impaired NO-dependent signaling play a central role in the adverse vasomotor effects. Given the broader impairment of vasomotor function we observed here and in a previous study in which a transient cycling diesel engine was used, 16 we acknowledge that we cannot discount upregulation of other circulating or cellular vasoconstrictor mediators (such as Rho kinase 34 ) or activation of the sympathetic nervous system as an alternative explanation for the general blunting of vasodilator responses observed.
Limitations
Our principal objective was to assess the impact of a commercially available particle trap on markers of cardiovascular health by comparing the effects of unfiltered and filtered diesel exhaust. In this regard, we clearly demonstrate that vasodilatation, endothelial tPA release, and thrombus formation are improved by particle filtration. However, we acknowledge that our approach has limitations. The use of multiple and complementary surrogates of cardiovascular health is both a strength and a weakness of this study. Replication of previous observations suggests that the findings are real and provides a clear and consistent message: Diesel exhaust impairs vascular function 11, 16, 18 and increases ex vivo thrombus formation. 13 The use of multiple end points with 3 exposure conditions requires multiple comparisons and increases the possibility of type I and II errors. We have not adjusted for multiple comparisons because the initial comparison between diesel exhaust and filtered air was made simply to confirm our previous findings. Both the direction and magnitude of the changes seen here are consistent with our previous findings, although the differences in net tPA release failed to achieve statistical significance. Although the study was powered prospectively on the basis of measurements of the primary end points made during previous diesel exposure studies, we acknowledge that the sample size is modest. Although we are confident that we have not missed effects on endothelial function or ex vivo thrombosis, we acknowledge that we may have insufficient power to detect changes in some of the secondary end points (Table I in the online-only Data Supplement), and thus cannot exclude the possibility of false-negative findings confounding their assessment. In addition, the study cohort consisted exclusively of young, healthy men. Although one might postulate that the benefit of particle traps may actually be greater in those with preexisting cardiovascular disease, we concede that further studies are required to assess the role of particle traps in mitigating cardiovascular effects in women and the broader population.
Conclusion
With the use of several surrogate measures, a range of adverse cardiovascular effects of diesel exhaust inhalation in men appears to be prevented by the introduction of a particle trap. Given these beneficial effects on biomarkers of cardiovascular health, the widespread use of particle traps on diesel-powered vehicles may have substantial public health benefit and reduce the burden of cardiovascular disease.
CLINICAL PERSPECTIVE
There is a robust and consistent association between air pollution and cardiovascular morbidity and mortality. These harmful effects are most strongly associated with exposure to traffic-derived fine particles that predominantly originate from diesel engine exhaust emissions. Using a purpose-built exposure chamber, we have demonstrated previously the adverse vascular and prothrombotic effects of exposure to diesel exhaust in healthy men. In the present study, using complementary and relevant measures of cardiovascular health, we have reconfirmed the adverse effects of exposure to diesel engine exhaust on endothelial function and ex vivo thrombosis. In addition, for the first time, we demonstrate that reducing the particulate component of diesel exhaust with a commercially available particle trap can prevent these detrimental cardiovascular effects. Our study provides support for the application of particle traps to diesel-powered vehicles to reduce urban particulate concentrations and limit a range of adverse cardiovascular effects related to exposure to traffic-derived air pollution.
